EXHIBIT I

 

JOINT FILING AGREEMENT

 

This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of ANI Pharmaceuticals, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

Dated: January 17, 2025 

 

 

MILLENNIUM MANAGEMENT LLC

 

By: /s/ Gil Raviv                                         

Name: Gil Raviv

Title: Global General Counsel

 

 

 

MILLENNIUM GROUP MANAGEMENT LLC

 

By: /s/ Gil Raviv                                         

Name: Gil Raviv

Title: Global General Counsel

 

 

/s/Israel A. Englander                                

Israel A. Englander 

 

 

 

ANI Pharmaceuticals (NASDAQ:ANIP)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse ANI Pharmaceuticals
ANI Pharmaceuticals (NASDAQ:ANIP)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse ANI Pharmaceuticals